SCHEMBL7051639

SCHEMBL7051639

CCCOc1ccc2[nH]cc(C(C)CNC=O)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.52
MTNR1B P49286 1/20 0.52
HTT P42858 1/20 0.48
HTR1B P28222 11/20 0.48
HTR1A P08908 10/20 0.48
HTR2A P28223 2/20 0.47
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
TRPV1 Q8NER1 2/20 0.44
HTR1D P28221 9/20 0.43
MAPT P10636 2/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052855 0.92 MTNR1A (0.55) MTNR1AMTNR1BHTTHTR2AHTR2C
SCHEMBL7056044 0.78 MTNR1A (0.61) MTNR1AMTNR1BHTTHTR1BHTR1A
SCHEMBL8822709 0.77 MTNR1A (0.68) MTNR1AMTNR1BHTR1AHTR2AHTR2C
SCHEMBL24358705 0.75 HTR1B (0.60) MTNR1AMTNR1BHTTHTR1BHTR1A
SCHEMBL7055084 0.74 MTNR1A (0.54) MTNR1AMTNR1BHTTHTR1AHTR2A
SCHEMBL7053288 0.70 MTNR1A (0.52) MTNR1AMTNR1BHTR2AHTR2CHTR2B
SCHEMBL6279118 0.70 THRA (0.48) MTNR1AMTNR1BHTTHTR1BHTR1A
SCHEMBL17949489 0.69 HTR2A (0.58) MTNR1AMTNR1BHTR1BHTR1AHTR2A
SCHEMBL7056049 0.69 MTNR1A (0.61) MTNR1AMTNR1BHTR2AHTR2CHTR2B
SCHEMBL23259141 0.69 HTR2A (0.53) MTNR1AMTNR1BHTR1BHTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0656209-B1 Melatonin derivatives for use in treating desynchronization disorders LILLY CO ELI (US) 2003-05-07 EP disclosed
EP-0655243-B1 Melatonin derivatives for use in treating sleep disorders LILLY CO ELI (US) 2002-08-21 EP disclosed
US-6180657-B1 SLEEP DISORDERS ELI LILLY AND COMPANY 2001-01-30 US disclosed
US-5770610-A ADMINISTERING R-(+)-N-(2-METHYL-2-(5-METHOXY-6-CHLOROINDOL-3-YL)ETHYL) ACETAMIDE ELI LILLY AND COMPANY (US) 1998-06-23 US disclosed
US-5654325-A Melatonin derivatives for use in treating sleep disorders ELI LILLY AND COMPANY (US) 1997-08-05 US disclosed
EP-0748627-A2 Melatonin agonists for use in the treatment of benign prostatic hyperplasia ELI LILLY AND COMPANY (US) 1996-12-18 EP disclosed
EP-0656209-A2 Melatonin derivatives for use in treating desynchronization disorders ELI LILLY AND COMPANY (US) 1995-06-07 EP disclosed
EP-0655243-A2 Melatonin derivatives for use in treating sleep disorders ELI LILLY AND COMPANY (US) 1995-05-31 EP disclosed
US-4997845-A β-alkylmelatonins as ovulation inhibitors ELI LILLY AND COMPANY (US) 1991-03-05 US disclosed